After years of inflation-proof growth, the pharmaceutical industry is being confronted by a series of obstacles.

Falling returns have prompted partnerships, alliances and M&As. A search for new markets has generated the expansion of distribution networks into the developing world. High-value pharmaceutical products are a globally attractive target for product counterfeiting. By the nature of their business, pharmaceutical companies can be a frequent target for single issue and other activist groups. Added to these risks are differential pricing between markets, the development of 'grey market' trading and infringements of companies' intellectual property rights.

To help our clients understand and handle the current and potential risks they face, Control Risks provides:

• Political and security risk analysis – we provide country-specific information.
• Brand protection/anti-counterfeiting consultancy – we can help to manage potential threats and investigate counterfeiting, leading to the closure of such operations. We can assist in the prevention of product diversion and the theft of trade secrets.
• Information security – we can consult on physical and information security policies and procedures, security audits, and fraud awareness training or investigation.
• Security management – we provide strategic and practical assistance to protect all assets: people, property, intellectual rights and reputation.
• Counter-terrorism consultancy – we help pharmaceutical companies overcome operational problems caused by single issue groups.